M. Karmazyn, Mechanisms of protection of the ischemic and reperfused myocardium by sodium-hydrogen exchange inhibition, J THROMB TH, 8(1), 1999, pp. 33-38
Sodium-hydrogen exchange (Na-H exchange) is a major regulator of intracellu
lar pH and is one of the major mechanisms for restoring pH after ischemia-i
nduced intracellular acidosis. However, activation of Na-H exchange during
ischemia and reperfusion is also involved in paradoxical induction of cell
injury. This likely reflects the fact that activation of the exchanger is c
losely coupled to sodium influx and, as a consequence, to elevation in intr
acellular calcium concentrations through sodium-calcium exchange. In additi
on to intracellular acidosis, other factors can also stimulate the exchange
r, including various autocrine and paracrine factors, such as endothelin-1,
angiotensin II, alpha(1)-adrenergic agonists, as well as toxic agents, suc
h as hydrogen peroxide and lysophosphatidylcholine. Although at least six N
a-H exchange isoforms have thus far been identified, it appears that the 1
subtype, termed NHE1, is the predominant isoform in the mammalian myocardiu
m. Effective pharmacological inhibitors of Na-H exchange, including those t
hat are NHE1 specific, have been extensively demonstrated to protect the is
chemic and reperfused myocardium in terms of improved systolic and diastoli
c function, preservation of cellular ultrastructure, attenuation of the inc
idence of arrhythmias, and reduction of apoptosis. Moreover, the salutary e
ffects of these agents have been demonstrated using a variety of experiment
al models as well as animal species, suggesting that the role of Na-H excha
nge in mediating injury is not species specific. Thus, Na-H exchange repres
ents an important target for pharmacological intervention in attenuation of
ischemia and reperfusion-induced cardiac injury. Coupled with the low pote
ntial for toxicity of the agents, Na-H exchange inhibition could emerge as
an effective therapeutic strategy in cardiac disorders, particularly involv
ing conditions associated with ischemia and reperfusion.